Effects of combined treatment with zibotentan and dapagliflozin compared to dapagliflozin alone in patients with diabetic and non-diabetic chronic kidney disease.
Saved in:
| Title: | Effects of combined treatment with zibotentan and dapagliflozin compared to dapagliflozin alone in patients with diabetic and non-diabetic chronic kidney disease. |
|---|---|
| Authors: | Wasehuus V; Steno Diabetes Center Copenhagen, Herlev, Denmark., Smeijer JD; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Ambery P; BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Greasley PJ; BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Wijkmark E; BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Wheeler DC; Centre for Kidney and Bladder Health, University College London, London, UK., Rossing P; Steno Diabetes Center Copenhagen, Herlev, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Heerspink HJL; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; George Institute for Global Health, Barangaroo, New South Wales, Australia. |
| Source: | Diabetes, obesity & metabolism [Diabetes Obes Metab] 2025 Aug; Vol. 27 (8), pp. 4311-4319. Date of Electronic Publication: 2025 May 21. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase II; Comparative Study |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40396470 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Effects of combined treatment with zibotentan and dapagliflozin compared to dapagliflozin alone in patients with diabetic and non-diabetic chronic kidney disease. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Wasehuus+V%22">Wasehuus V</searchLink>; Steno Diabetes Center Copenhagen, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Smeijer+JD%22">Smeijer JD</searchLink>; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Ambery+P%22">Ambery P</searchLink>; BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Greasley+PJ%22">Greasley PJ</searchLink>; BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Wijkmark+E%22">Wijkmark E</searchLink>; BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Wheeler+DC%22">Wheeler DC</searchLink>; Centre for Kidney and Bladder Health, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Rossing+P%22">Rossing P</searchLink>; Steno Diabetes Center Copenhagen, Herlev, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Heerspink+HJL%22">Heerspink HJL</searchLink>; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; George Institute for Global Health, Barangaroo, New South Wales, Australia. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100883645%22">Diabetes, obesity & metabolism</searchLink> [Diabetes Obes Metab] 2025 Aug; Vol. 27 (8), pp. 4311-4319. <i>Date of Electronic Publication: </i>2025 May 21. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase II; Comparative Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100883645 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1463-1326 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214628902%22">14628902 </searchLink><i>NLM ISO Abbreviation: </i>Diabetes Obes Metab <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40396470 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/dom.16468 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 4311 Titles: – TitleFull: Effects of combined treatment with zibotentan and dapagliflozin compared to dapagliflozin alone in patients with diabetic and non-diabetic chronic kidney disease. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Wasehuus V – PersonEntity: Name: NameFull: Smeijer JD – PersonEntity: Name: NameFull: Ambery P – PersonEntity: Name: NameFull: Greasley PJ – PersonEntity: Name: NameFull: Wijkmark E – PersonEntity: Name: NameFull: Wheeler DC – PersonEntity: Name: NameFull: Rossing P – PersonEntity: Name: NameFull: Heerspink HJL IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: 2025 Aug Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1463-1326 Numbering: – Type: volume Value: 27 – Type: issue Value: 8 Titles: – TitleFull: Diabetes, obesity & metabolism Type: main |
| ResultId | 1 |
